Fate’s management team has the passion and experience to explore new biology, develop innovative therapeutics, create formidable intellectual property, launch new business models and foster high-value strategic collaborations.

Scott Wolchko
Scott Wolchko
President & CEO
Dan Shoemaker
Dan Shoemaker, Ph.D.
Chief Scientific Officer
Chris Storgard
Chris Storgard, M.D.
Chief Medical Officer
3bio goes here
Cindy Tahl
Cindy Tahl, J.D.
General Counsel
Bob Valamehr
Bob Valamehr, Ph.D.
Vice President of Cancer Immunotherapy
Jim Beitel
Jim Beitel
Senior Vice President, Corporate Development
6bio goes here